EGF and Paroxysmal atrial fibrillation: The results of this trial were presented and are pending publication, but showed that EGF-identified, extra-pulmonary vein sources were detected in 60% of a difficult-to-treat redo population of non-paroxysmal AF patients after undergoing successful Pulmonary Vein Isolation (PVI).